Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 32 results.
User Information
Export Records
  1. 1.   Regulation of inflammation by members of the formyl-peptide receptor family
  2. Chen, Keqiang; Bao, Zhiyao; Gong, Wang; Tang, Peng; Yoshimura, Teizo; Wang, Jiming
  3. JOURNAL OF AUTOIMMUNITY. 2017, DEC; 85: 64-77.
  1. 2.   HCV Peptide (C5A), an Amphipathic alpha-Helical Peptide of Hepatitis Virus C, Is an Activator of N-Formyl Peptide Receptor in Human Phagocytes
  2. Lin, Q.; Fang, D.; Hou, X. W.; Le, Y. Y.; Fang, J. H.; Wen, F.; Gong, W. H.; Chen, K. Q.; Wang, J. M.; Su, S. B.
  3. Journal of Immunology. 2011, Feb; 186(4): 2087-2094.
  1. 3.   Cutting Edge: A Critical Role for the G Protein-Coupled Receptor mFPR2 in Airway Inflammation and Immune Responses
  2. Chen, K. Q.; Le, Y. Y.; Liu, Y.; Gong, W. H.; Ying, G. G.; Huang, J.; Yoshimura, T.; Tessarollo, L.; Wang, J. M.
  3. Journal of Immunology. 2010, Apr; 184(7): 3331-3335.
  1. 4.   The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells
  2. Huang, J.; Chen, K.; Chen, J.; Gong, W.; Dunlop, N. M.; Howard, O. M. Z.; Gao, Y.; Bian, X. W.; Wang, J. M.
  3. British Journal of Cancer. 2010, Mar 16; 102(6): 1052-1060.
  1. 5.   Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation
  2. Huang, J.; Chen, K. Q.; Huang, J. Q.; Gong, W. H.; Dunlop, N. M.; Howard, O.; Bian, X. W.; Gao, Y. Q.; Wang, J. M.
  3. Carcinogenesis. 2009 30(2): 348-355.
  1. 6.   Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR
  2. Yao, X. H.; Ping, Y. F.; Chen, J. H.; Xu, C. P.; Chen, D. L.; Zhang, R.; Wang, J. M.; Bian, X. W.
  3. Journal of Pathology. 2008 215(4): 369-376.
  1. 7.   A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors
  2. Chen, J. H.; Yao, X. H.; Gong, W.; Hu, J.; Zhou, X. D.; Chen, K.; Liu, H.; Ping, Y. F.; Wang, J. M.; Bian, X. W.
  3. Journal of Neuro-Oncology. 2007, Sep; 84(3): 223-231.
  1. 8.   Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival
  2. Bian, X. W.; Yang, S. X.; Chen, L. H.; Ping, Y. F.; Zhou, X. D.; Wang, Q. L.; Jiang, X. F.; Gong, W. H.; Xiao, H. L.; Du, L. L.; Chen, Z. Q.; Zhao, W.; Shi, L. Q.; Wang, J. M.
  3. Neurosurgery. 2007, Sep; 61(3): 570-578.
  1. 9.   The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells
  2. Ping, Y. F.; Yao, X. H.; Chen, J. H.; Liu, H.; Chen, D. L.; Zhou, X. D.; Wang, J. M.; Bian, X. W.
  3. Journal of Neuro-Oncology. 2007, Aug; 84(1): 21-29.
  1. 10.   Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells
  2. Huang, J.; Hu, J. Y.; Bian, X. W.; Chen, K. Q.; Gong, W. H.; Dunlop, N. M.; Howard, O. M. Z.; Wang, J. M.
  3. Cancer Research. 2007, Jun; 67(12): 5906-5913.
  1. 11.   RNA interference as a novel and powerful tool in immunopharmacological research
  2. Kong, Y.; Ruan, L. F.; Ma, L. L.; Cui, Y. H.; Wang, J. M.; Le, Y. Y.
  3. International Immunopharmacology. 2007, Apr; 7(4): 417-426.
  1. 12.   Formylpeptide receptor FPR and the rapid growth of malignant human gliomas
  2. Zhou, Y.; Bian, X. W.; Le, Y. Y.; Gong, W. H.; Hu, J. Y.; Zhang, X.; Wang, L. H.; Iribarren, P.; Salcedo, R.; Howard, O. M. Z.; Farrar, W.; Wang, J. M.
  3. Journal of the National Cancer Institute. 2005, JUN 1; 97(11): 823-835.
  1. 13.   Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity
  2. Hu, J. Y.; Li, G. C.; Tong, Y. Q.; Li, Y. H.; Zhou, G. H.; He, X. J.; Xie, P. L.; Wang, J. M.; Sun, Q. B.
  3. International Immunopharmacology. 2005, JUN; 5(6): 971-980.
  1. 14.   Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as immune adjuvant
  2. Kurosaka, K.; Chen, Q.; Yarovinsky, F.; Oppenheim, J. J.; Yang, D.
  3. Journal of Immunology. 2005, MAY 15; 174(10): 6257-6265.
  1. 15.   Silencing the formylpeptide receptor FPR by short-interfering RNA
  2. Le, Y. Y.; Iribarren, P.; Zhou, Y.; Gong, W. H.; Hu, J. Y.; Zhang, X.; Wang, J. M.
  3. Molecular Pharmacology. 2004, OCT; 66(4): 1022-1028.
  1. 16.   Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose
  2. Partida-Sanchez, S.; Iribarren, P.; Moreno-Garcia, M. E.; Gao, X. L.; Murphy, P. M.; Oppenheimer, N.; Wang, J. M.; Lund, F. E.
  3. Journal of Immunology. 2004 172(3): 1896-1906.
  1. 17.   Humanin, a newly identified neuroprotective factor, uses the g protein-coupled formylpeptide receptor-like-1 as a functional receptor
  2. Ying, G. G.; Iribarren, P.; Zhou, Y.; Gong, W. H.; Zhang, N.; Yu, Z. X.; Le, Y.; Cui, Y.; Wang, J. M.
  3. Journal of Immunology. 2004 172(11): 7078-7085.
  1. 18.   Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor
  2. Sun, R. H.; Iribarren, P.; Zhang, N.; Zhou, Y.; Gong, W. H.; Cho, E. H.; Lockett, S.; Chertov, O.; Bednar, F.; Rogers, T. J.; Oppenheim, J. J.; Wang, J. M.
  3. Journal of Immunology. 2004 173(1): 428-436.
  1. 19.   Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells
  2. Cui, Y. H.; Le, Y. Y.; Gong, W. H.; Proost, P.; Van Damme, J.; Murphy, W. J.; Wang, J. M.
  3. Journal of Immunology. 2002 168(1): 434-442.
  1. 20.   Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation
  2. Yang, D.; Chen, Q.; Gertz, B.; He, R.; Phulsuksombati, M.; Ye, R. D.; Oppenheim, J. J.
  3. Journal of Leukocyte Biology. 2002 72(3): 598-607.
  1. 21.   Up-regulation of FPR2, a chemotactic receptor for amyloid beta 1-42 (A beta(42)), in murine microglial cells by TNF alpha
  2. Cui, Y. H.; Le, Y.; Zhang, X.; Gong, W.; Abe, K.; Sun, R.; Van Damme, J.; Proost, P.; Wang, J. M.
  3. Neurobiology of Disease. 2002 10(3): 366-377.
  1. 22.   Manipulating chemoattractant and receptor genes
  2. Le, Y. Y.; Cui, Y. H.; Iribarren, P.; Ying, G. G.; Wang, J. M.
  3. In Vivo. 2002 16(1): 1-23.
  1. 23.   Receptors for chemotactic formyl peptides as pharmacological targets
  2. Le, Y. Y.; Yang, Y. M.; Cui, Y. H.; Yazawa, H.; Gong, W. H.; Qiu, C. P.; Wang, J. M.
  3. International Immunopharmacology. 2002 2(1): 1-13.
  1. 24.   Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease
  2. Cui, Y. H.; Le, Y. Y.; Yazawa, H.; Gong, W. H.; Wang, J. M.
  3. Journal of Leukocyte Biology. 2002 72(4): 628-635.
  1. 25.   Formyl-peptide receptors revisited
  2. Le, Y. Y.; Murphy, P. M.; Wang, J. M.
  3. Trends in Immunology. 2002 23(11): 541-548.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel